Product Suite &
Market-ready assets include management tools for advanced wound care and dermatitis. Pipeline assets include FleX™ Antimicrobial, an antimicrobial regenerative collagen powder, as well as Xeal® Silicone, a non-adherent, antimicrobial silicone dressing.
We are engaged in the pursuit of drug therapies for the treatment of onychomycosis, herpes zoster opthalmicus, and COVID-19.
***CDC Emerging Threat